On 19 October 2026, President Donald Trump signed a significant executive order aimed at elevating women’s health issues within federal medical research. This initiative, reportedly inspired by First Lady Melania Trump, mandates the establishment of a new women’s health division at the National Institutes of Health (NIH) and a dedicated task force at the White House.
:max_bytes(150000):strip_icc():format(jpeg)/donald-trump-melania-trump-101926-47c4e52821954d0cafad3a12fcd5f5ca.jpg)
At a ceremony held in the Rose Garden, President Trump underscored the importance of this order, stating it would address the often-overlooked health concerns facing women. He articulated that the new measures would focus on “promoting new research” into diseases that disproportionately affect women, emphasising the need for innovation in medical diagnostics and treatment methodologies.
The task force, tasked with developing and implementing these initiatives, will be headed by White House Chief of Staff Susie Wiles and Health and Human Services Secretary Robert F. Kennedy Jr. Wiles, who publicly shared her breast cancer diagnosis earlier this year, expressed a personal commitment to the cause, having recently announced her recovery from the disease. Trump remarked that both Wiles and Melania share a deep concern for advancing women’s health, reinforcing the administration’s focus on health equity.
During her remarks, Melania Trump made it clear that the executive order aims to reshape the landscape of women’s health in America. “Beginning today, we will change the reality of women’s health,” she proclaimed, highlighting the previous generations’ efforts towards women’s rights. She voiced a commitment to ensuring that women can lead healthy lives and fully realise their potential.
President Trump echoed these sentiments, framing the initiative as a groundbreaking step in addressing health disparities. He noted that the order would not only encourage new research but also advocate for innovative technologies that would allow for earlier diagnoses and improved treatment options based on the latest scientific advancements.
Following the signing of the order, an exchange ensued between the President and First Lady. Trump encouraged Melania to add her signature, jokingly questioning its significance, to which she responded that his signature held the greater weight. Their interaction underscored a collaborative spirit in the initiative, although Melania’s prior involvement in similar ceremonies had primarily been symbolic.
The executive order outlines specific areas of research to be prioritised, including maternal health, mental health, infertility, and conditions such as endometriosis and fibroids, which have often been underfunded and under-researched. Trump characterised the effort as “historic,” attributing the genesis of the initiative directly to Melania’s vision and commitment to women’s health.
Although the NIH has an existing Office of Research on Women’s Health, established in 1990, Trump expressed concern that women’s health issues had not received the attention they deserved. He visualised the new division as a necessary evolution, posing the rhetorical question, “Who the hell wouldn’t have a women’s health division?”
The announcement of this task force is part of a broader movement within the government to uplift women’s health issues, following former President Joe Biden’s earlier efforts to advance similar initiatives, which included a call to Congress in 2024 for a $12 billion fund dedicated to women’s health research.
As the new task force is set to convene for its first meeting, the outcomes of this executive order could mark a pivotal turning point in prioritising women’s health in the scope of federal research and action. The commitment from the highest levels of government signals a renewed focus on addressing the unique health challenges faced by women and fostering a more equitable healthcare landscape.